Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NVO | JNJ | PFE | LLY | ABBV |
| Company | Novo Nordisk A/S ADR | Johnson & Johnson | Pfizer Inc | Eli Lilly and Company | Abbvie Inc |
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | NYSE | NYSE |
| Open | 126.57 | 149.86 | 26.33 | 741.20 | 168.59 |
| High | 128.76 | 150.49 | 26.47 | 746.16 | 170.37 |
| Low | 126.34 | 148.20 | 26.19 | 731.44 | 168.22 |
| Last | 128.64 | 149.56 | 26.32 | 745.69 | 169.54 |
| Change | +3.38 | +0.44 | +0.06 | +14.36 | +1.65 |
| % Change | +2.70% | +0.30% | +0.23% | +1.96% | +0.98% |
| Volume | 3,703,600 | 10,110,400 | 24,297,800 | 2,042,000 | 4,084,100 |
| 20-Day Average Volume | 3,569,295 | 7,934,000 | 36,157,035 | 2,408,575 | 5,270,200 |
| Previous Close | 125.26 | 149.12 | 26.26 | 731.33 | 167.89 |
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 125.75 | 151.31 | 26.59 | 759.46 | 170.70 |
| 20-Day Raw Stochastic | 81.84% | 40.16% | 37.72% | 32.99% | 42.78% |
| 20-Day Relative Strength | 56.32% | 41.21% | 44.47% | 48.72% | 47.16% |
| Weighted Alpha | +58.70 | -9.66 | -31.72 | +80.97 | +15.10 |
| Today's Opinion | 72% Buy | 88% Sell | 100% Sell | 40% Buy | 40% Buy |
| Previous Opinion | 40% Buy | 88% Sell | 100% Sell | 40% Buy | 40% Buy |
| Last Month's Opinion | 88% Buy | 40% Sell | 72% Sell | 100% Buy | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.20% since 04/16/24 | +3.54% since 04/16/24 | +2.45% since 04/16/24 | -0.14% since 04/16/24 | +4.31% since 04/16/24 |
| Low | 122.46 on 04/19/24 | 143.13 on 04/18/24 | 25.23 on 04/18/24 | 722.07 on 04/19/24 | 163.23 on 04/17/24 |
| High | 128.76 on 04/23/24 | 150.49 on 04/23/24 | 26.50 on 04/22/24 | 771.83 on 04/17/24 | 170.37 on 04/23/24 |
| 1-Month | |||||
| %Chg | -0.09% since 03/22/24 | -3.65% since 03/22/24 | -3.80% since 03/22/24 | -3.23% since 03/22/24 | -4.99% since 03/22/24 |
| Low | 121.79 on 04/16/24 | 143.13 on 04/18/24 | 25.23 on 04/18/24 | 722.07 on 04/19/24 | 160.00 on 04/12/24 |
| High | 130.25 on 03/25/24 | 159.14 on 03/28/24 | 28.12 on 03/28/24 | 793.67 on 03/28/24 | 182.30 on 03/28/24 |
| 3-Month | |||||
| %Chg | +22.08% since 01/23/24 | -6.41% since 01/23/24 | -7.42% since 01/23/24 | +18.42% since 01/23/24 | +1.22% since 01/23/24 |
| Low | 104.81 on 01/25/24 | 143.13 on 04/18/24 | 25.23 on 04/18/24 | 624.68 on 01/25/24 | 160.00 on 04/12/24 |
| High | 138.28 on 03/07/24 | 163.11 on 03/12/24 | 28.77 on 01/24/24 | 800.78 on 03/04/24 | 182.89 on 03/12/24 |
| 6-Month | |||||
| %Chg | +32.45% since 10/23/23 | -1.21% since 10/23/23 | -14.66% since 10/23/23 | +29.31% since 10/23/23 | +17.14% since 10/23/23 |
| Low | 92.94 on 10/27/23 | 143.13 on 04/18/24 | 25.23 on 04/18/24 | 547.61 on 10/31/23 | 135.85 on 11/09/23 |
| High | 138.28 on 03/07/24 | 163.58 on 01/22/24 | 31.41 on 11/06/23 | 800.78 on 03/04/24 | 182.89 on 03/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 562,108,288 | 359,346,848 | 148,698,352 | 694,883,456 | 297,273,920 |
| Shares Outstanding, K | 4,487,532 | 2,409,783 | 5,662,542 | 950,164 | 1,770,647 |
| Annual Sales | 33,724,300,000 | 85,159,000,000 | 58,496,000,000 | 34,124,100,000 | 54,318,000,000 |
| Annual Net Income | 12,150,770,000 | 35,153,000,000 | 2,119,000,000 | 5,240,400,000 | 4,863,000,000 |
| Last Quarter Sales | 9,526,160,000 | 21,383,000,000 | 14,248,000,000 | 9,353,400,000 | 14,301,000,000 |
| Last Quarter Net Income | 3,175,360,000 | 5,354,000,000 | -3,369,000,000 | 2,189,700,000 | 822,000,000 |
| 60-Month Beta | 0.41 | 0.53 | 0.61 | 0.34 | 0.58 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.71 on 01/31/24 | 2.71 on 04/16/24 | 0.10 on 01/30/24 | 2.49 on 02/06/24 | 2.79 on 02/02/24 |
| Latest Earnings Date | 05/02/24 | 04/16/24 | 05/01/24 | 04/30/24 | 04/26/24 |
| Most Recent Dividend | 0.663 on 03/22/24 | 1.190 on 02/16/24 | 0.420 on 01/25/24 | 1.300 on 02/14/24 | 1.550 on 04/12/24 |
| Next Ex-Dividends Date | 03/22/24 | 05/20/24 | 01/25/24 | 02/14/24 | 04/12/24 |
| Ratios | |||||
| Price/Earnings ttm | 45.36 | 14.14 | 14.21 | 114.92 | 14.98 |